{"organizations": [], "uuid": "48b1c2d577e7484a26577305e5a8ca82f917e8a2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-aclaris-says-first-patient-dosed-i/brief-aclaris-says-first-patient-dosed-in-pilot-study-with-ati-502-topical-idUSFWN1S00N6", "country": "US", "domain_rank": 408, "title": "BRIEF-Aclaris Says First Patient Dosed In Pilot Study With ATI-502 Topical", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-23T14:48:00.000+03:00", "replies_count": 0, "uuid": "48b1c2d577e7484a26577305e5a8ca82f917e8a2"}, "author": "", "url": "https://www.reuters.com/article/brief-aclaris-says-first-patient-dosed-i/brief-aclaris-says-first-patient-dosed-in-pilot-study-with-ati-502-topical-idUSFWN1S00N6", "ord_in_thread": 0, "title": "BRIEF-Aclaris Says First Patient Dosed In Pilot Study With ATI-502 Topical", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "aclaris therapeutics inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "ati-502 topical reuters staff", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 23, 2018 / 11:50 AM / Updated 10 minutes ago BRIEF-Aclaris Says First Patient Dosed In Pilot Study With ATI-502 Topical Reuters Staff 1 Min Read \nApril 23 (Reuters) - Aclaris Therapeutics Inc: \n* ACLARIS THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN A PILOT STUDY WITH ATI-502 TOPICAL IN PATIENTS WITH ANDROGENETIC ALOPECIA Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-23T14:48:00.000+03:00", "crawled": "2018-04-23T15:05:05.003+03:00", "highlightTitle": ""}